Bryan J. Johnson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Bryan J. Johnson has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
- James DeGregori
University of Colorado Anschutz Medical Campus
2 shared publications Afshin Beheshti
COVID-19 International Research Team, Medford, USA
1 shared publication- Andreia N. Cadar
Center on Aging UConn Health Farmington Connecticut USA
1 shared publication Andrew Goodspeed
University of Colorado Comprehensive Cancer Center, University of Colorado Anschutz Medical Campus, Aurora, USA
1 shared publication- Bennett J. Davenport
Department of Immunology and Microbiology, University of Colorado School of Medicine, Aurora, USA
1 shared publication - Bin Yu
Department of Molecular, Cellular, and Developmental Biology, University of Colorado, Boulder, CO, USA
1 shared publication
Latest Publications
- Open Access
- 4 May 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Cathepsin B protease mediates high population density-induced mutagenesis to drive genome evolution and competitive growth
Density-dependent population regulation is widespread in the animal kingdom, but the underlying molecular mechanisms remain poorly understood. Here, we show that C. elegans animals respond to crowding stress by secreting CPR-4, a homologue of human cathepsin B cysteine protease, leading to chromosomal DNA damage in germ cells and high density-induced deficiencies that include increased embryonic lethality and larval arrest and decreased brood size. CPR-4 mediates these crowding responses through the insulin-like growth factor receptor DAF-2, multiple components in the insulin signaling pathway, and the SKN-1/Nrf transcription factor. Whole genome sequencing analyses of animals from 10 generations of continual growth in the crowded condition reveal that CPR-4-induced DNA damage produces an average of 2.8 more de novo genome mutations per animal per generation and a 87% increase in mutation rate compared with animals grown in the uncrowded condition. CPR-4-induced mutagenesis also facilitates evolution of the genomes through multi-generational crowding selection, leading to biased mutation distributions towards the intergenic regions over the gene bodies and crowd-dependent growth advantage. Therefore, CPR-4 acts as a crucial crowd-responding factor to induce genome mutagenesis, driving genome evolution and competitive growth of animals in response to crowding stress.
- 4 May 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Open AccessCathepsin B protease mediates high population density-induced mutagenesis to drive genome evolution and competitive growth
Density-dependent population regulation is widespread in the animal kingdom, but the underlying molecular mechanisms remain poorly understood. Here, we show that C. elegans animals respond to crowding stress by secreting CPR-4, a homologue of human cathepsin B cysteine protease, leading to chromosomal DNA damage in germ cells and high density-induced deficiencies that include increased embryonic lethality and larval arrest and decreased brood size. CPR-4 mediates these crowding responses through the insulin-like growth factor receptor DAF-2, multiple components in the insulin signaling pathway, and the SKN-1/Nrf transcription factor. Whole genome sequencing analyses of animals from 10 generations of continual growth in the crowded condition reveal that CPR-4-induced DNA damage produces an average of 2.8 more de novo genome mutations per animal per generation and a 87% increase in mutation rate compared with animals grown in the uncrowded condition. CPR-4-induced mutagenesis also facilitates evolution of the genomes through multi-generational crowding selection, leading to biased mutation distributions towards the intergenic regions over the gene bodies and crowd-dependent growth advantage. Therefore, CPR-4 acts as a crucial crowd-responding factor to induce genome mutagenesis, driving genome evolution and competitive growth of animals in response to crowding stress.
- Top Cited PapersOpen Access
- 30 July 2025
- Published by Springer Nature in Nature
- Vol. 645 (8080) , 496-506
Respiratory viral infections awaken metastatic breast cancer cells in lungs
Breast cancer is the second most common cancer globally, with most deaths caused by metastatic disease, often following long periods of clinical dormancy1. Understanding the mechanisms that disrupt the quiescence of dormant disseminated cancer cells (DCCs) is crucial for addressing metastatic progression. Infections caused by respiratory viruses such as influenza and SARS-CoV-2 trigger both local and systemic inflammation2,3. Here we demonstrate, in mice, that influenza and SARS-CoV-2 infections lead to loss of the pro-dormancy phenotype in breast DCCs in the lung, causing DCC proliferation within days of infection and a massive expansion of carcinoma cells into metastatic lesions within two weeks. These phenotypic transitions and expansions are interleukin-6 dependent. We show that DCCs impair lung T cell activation and that CD4+ T cells sustain the pulmonary metastatic burden after the influenza infection by inhibiting CD8+ T cell activation and cytotoxicity. Crucially, these experimental findings align with human observational data. Analyses of cancer survivors from the UK Biobank (all cancers) and Flatiron Health (breast cancer) databases reveal that SARS-CoV-2 infection substantially increases the risk of cancer-related mortality and lung metastasis compared with uninfected cancer survivors. These discoveries underscore the huge impact of respiratory viral infections on metastatic cancer resurgence, offering new insights into the connection between infectious diseases and cancer metastasis.
- 30 July 2025
- Published by Springer Nature in Nature
- Vol. 645 (8080) , 496-506
Top Cited PapersOpen AccessRespiratory viral infections awaken metastatic breast cancer cells in lungs
Breast cancer is the second most common cancer globally, with most deaths caused by metastatic disease, often following long periods of clinical dormancy1. Understanding the mechanisms that disrupt the quiescence of dormant disseminated cancer cells (DCCs) is crucial for addressing metastatic progression. Infections caused by respiratory viruses such as influenza and SARS-CoV-2 trigger both local and systemic inflammation2,3. Here we demonstrate, in mice, that influenza and SARS-CoV-2 infections lead to loss of the pro-dormancy phenotype in breast DCCs in the lung, causing DCC proliferation within days of infection and a massive expansion of carcinoma cells into metastatic lesions within two weeks. These phenotypic transitions and expansions are interleukin-6 dependent. We show that DCCs impair lung T cell activation and that CD4+ T cells sustain the pulmonary metastatic burden after the influenza infection by inhibiting CD8+ T cell activation and cytotoxicity. Crucially, these experimental findings align with human observational data. Analyses of cancer survivors from the UK Biobank (all cancers) and Flatiron Health (breast cancer) databases reveal that SARS-CoV-2 infection substantially increases the risk of cancer-related mortality and lung metastasis compared with uninfected cancer survivors. These discoveries underscore the huge impact of respiratory viral infections on metastatic cancer resurgence, offering new insights into the connection between infectious diseases and cancer metastasis.